Efficacy of transcranial direct stimulation on amplifation of neuropsychological function in patient with obsessive-compulsive disorder: A double-blind randomize clinical trial with the control group
Evaluation of direct and alternating electrical stimulation on amplifation of neuropsychological function in people with obsessive-compulsive disorder.
Design
A double-blind, randomized clinical trial with a control group on 40 patients. Random allocation software will be used for randomization.
Settings and conduct
40 patients will be randomly assigned into two groups of 20. This clinical trial is double-blind and the patient and the outcome assessor are not aware of the type of intervention. The study site will be Fatemi Hospital in Ardabil.
Participants/Inclusion and exclusion criteria
Inclusion criteria: diagnosis of schizophrenia based on DSM V; age:18-50 years old; required written informed consent signed by patients' guardian. Exclusion criteria: pregnancy; existence of metal implants in the body; history of neurological diseases.
Intervention groups
40 patients will be randomly assigned to two groups: sham and tDCS. The first group (tDCS) will receive 1.5 mA electrical stimulation in 20 sessions of 20 minutes in 10 days (2 sessions per day with an interval of 20 minutes). Stimulation will be performed in the praorbital left cathodal-cortex frontal inferior right anodal. Sham stimulation is as same as active stimulation, except that there will be no current and the device will turn off after one minute.
Efficacy of transcranial direct stimulation on amplifation of neuropsychological function in patient with obsessive-compulsive disorder: A double-blind randomize clinical trial with the control group
Public title
Direct electrical stimulation of the brain in obsessive-compulsive disorder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Diagnosis ofobsessive-compulsive disorder based on DSM V
Age: 18-50 years old
Required written informed consent signed by patients' guardian
Exclusion criteria:
History of neurological diseases such as seizures, strokes, or cerebrovascular diseases
The existence of metal implants in the body
Pregnancy
Age
From 18 years old to 50 years old
Gender
Both
Phase
N/A
Groups that have been masked
Participant
Outcome assessor
Sample size
Target sample size:
40
More than 1 sample in each individual
Number of samples in each individual:
20
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, we will use the Restricted Randomization method of block randomization and in each phase, we will have 4 blocks. Generation of random sequences via the blocking method will be done by Random Allocation software. To conceal, we use Allocation Concealment, which refers to the method used to perform a random sequence on study participants, so that the assigned group is not identified before the individual is assigned. Also, non-transparent envelopes sealed with random sequences will be used, that in this method each random sequence is recorded on a card and the cards are placed in the envelope in order. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lids of the envelopes are glued and placed inside a box, respectively. At the beginning of the registration, according to the order of entry of the eligible participants, one of the envelopes will be opened in order and the assigned group of the participant will be revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
The executive specialist of electrical brain stimulation will be aware of the research topic and will perform therapeutic interventions. He codes the patients and refers them to a psychologist to check the patient's mental state and record the relevant criteria based on the same code. The
patients will be tested in the same condition in the Neurotherapy room and the electrodes of the device will be connected to them, but they will not be aware of the type of stimulation. The experimenter who assesses outcome measures will be independent from the one who applied intervention and will be blind to stimulation condition. This method of double-blinding is based on previous works in the field of transcranial electrical stimulation (Gandinga et al., 2006). Accordingly, this study will be a double-blind study.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Ardabil University of Medical Sciences
Street address
End of University Street, Ardabil University of Medical Sciences
City
Ardabil
Province
Ardabil
Postal code
56189-85991
Approval date
2021-05-17, 1400/02/27
Ethics committee reference number
IR.ARUMS.REC.1400.081
Health conditions studied
1
Description of health condition studied
Obsessive-compulsive disorder
ICD-10 code
F42
ICD-10 code description
Obsessive-compulsive disorder
Primary outcomes
1
Description
Neuropsychological function
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Cambridge Neuropsychological Test Automated Battery (CANTAB)
2
Description
Working memory
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Cambridge Neuropsychological Test Automated Battery (CANTAB)
3
Description
Inhibition response
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Cambridge Neuropsychological Test Automated Battery (CANTAB)
4
Description
Cognitive flexibility
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Cambridge Neuropsychological Test Automated Battery (CANTAB)
5
Description
Executive functions
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Test Wisconsin Cards
6
Description
Severity of obsessive-compulsive symptoms
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Maudsley Obsessional-Compulsive Inventory
7
Description
Evaluation of anxiety symptoms
Timepoint
Before intervention (baseline 1, 2). after the intervention.14, 30 and 90 days after the intervention
Method of measurement
Beck Anxiety Inventory (BDI)
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: in this group, participants will receive supraorbital left cathodal-cortex and frontal inferior right anodal tDCS stimulation for 20 sessions of 20 minutes in 10 days (two sessions per day at 20-minute intervals) with an intensity of 1.5 mA .
Category
Treatment - Devices
2
Description
Control group: in this group, participants receive sham electrical stimulation with the sameactual stimulation protocol for 20 seations in 10 days, while the current generator increases the current to 1.5 mA in 30 seconds, and then gradually over a period of 30 seconds, the current reaches zero.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Department of Psychiatry, Fatemi Hospital
Full name of responsible person
Dr. Anita Azarkolah
Street address
Department of Psychiatry, Fatemi Hospital, Sareyn Station, Ardabil
City
Ardabil
Province
Ardabil
Postal code
5614733775
Phone
+98 45 3323 2025
Email
fatei@arums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Ardabil University of Medical Sciences
Full name of responsible person
Dr. Farhad Pourfarzi
Street address
Ardabil University of Medical Sciences Office Complex, End of University Street
City
Ardabil
Province
Ardabil
Postal code
56189-85991
Phone
+98 45 3353 4776
Email
f.pourfarzi@arums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Ardabil University of Medical Science
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Ardabil University of Medical Sciences
Full name of responsible person
Dr. Anita Azarkolah
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Psychiatrics
Street address
Department of Psychiatry, Fatemi Hospital, Sareyn station, Ardabil
City
Ardabil
Province
Ardabil
Postal code
5614733775
Phone
+98 45 3323 2520
Email
dra.azarkolah@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohammad Ali Salehinejad
Position
Research associate
Latest degree
Ph.D.
Other areas of specialty/work
Neuroscience
Street address
Institute of Cognitive and Brain Sciences, Shahid Beheshti University, Velenjak, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
198396411
Phone
+98 21 2243 1616
Email
salehinejadmohammadali@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Ardabil University of Medical Sciences
Full name of responsible person
Habibeh Salvat Ghojehbeiglou
Position
Psychology
Latest degree
Master
Other areas of specialty/work
Psychology
Street address
Department of Psychiatry, Fatemi Hospital, Sareyn station, Ardabil
City
Ardabil
Province
Ardabil
Postal code
5614733775
Phone
+98 45 3323 2520
Email
habibehsalvat@yahoo.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
Due to the confidentiality of the participant's personal characteristics
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
All collected data for the primary outcome measures only after anonymizing.
When the data will become available and for how long
Starting 12 months after publication
To whom data/document is available
Researchers working in academic and scientific institutions
Under which criteria data/document could be used
En To raise the level of knowledge about the treatment of OCD
From where data/document is obtainable
Raw data and documents generated for this study are available from the corresponding authors and institution on reasonable request.
What processes are involved for a request to access data/document
A formal request from person/institutions should be sent to the corresponding authers and corresponding institutions via email (for international users) and mail (for national users).